BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35988122)

  • 21. Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
    Fathallah N; Akaffou M; Haouari MA; Spindler L; Alam A; Barré A; Pommaret E; Fels A; de Parades V
    Tech Coloproctol; 2023 Dec; 27(12):1201-1210. PubMed ID: 36811811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study.
    Sirmai L; Pelletier AL; Gault N; Zallot C; Bouguen G; Bouchard D; Roland Nicaise P; Peyneau M; Sironneau S; Bittencourt MC; Petitcollin A; Fernandez P; Roblin X; Siproudhis L; Abramowitz L
    World J Gastroenterol; 2022 Mar; 28(9):961-972. PubMed ID: 35317057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing perianal Crohn's fistula in the anti-TNFα era.
    Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
    Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study.
    Alessandroni L; Kohn A; Cosintino R; Marrollo M; Papi C; Monterubbianesi R; Tersigni R
    Tech Coloproctol; 2011 Dec; 15(4):407-12. PubMed ID: 22011835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease.
    Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S
    World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of fistulising Crohn's disease.
    Hvas CL; Dahlerup JF; Jacobsen BA; Ljungmann K; Qvist N; Staun M; Tøttrup A
    Dan Med Bull; 2011 Oct; 58(10):C4338. PubMed ID: 21975159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pedictors of Perianal Fistula Relapse in Crohn's Disease.
    Malian A; Rivière P; Bouchard D; Pigot F; Eléouet-Kaplan M; Favreau-Weltzer C; Poullenot F; Laharie D
    Inflamm Bowel Dis; 2020 May; 26(6):926-931. PubMed ID: 31504542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
    Yarur AJ; Kanagala V; Stein DJ; Czul F; Quintero MA; Agrawal D; Patel A; Best K; Fox C; Idstein K; Abreu MT
    Aliment Pharmacol Ther; 2017 Apr; 45(7):933-940. PubMed ID: 28211593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
    Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
    de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
    Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative treatment of anal fistulas in Crohn's disease.
    Hermann J; Eder P; Banasiewicz T; Kołodziejczak B; Łykowska-Szuber L
    ANZ J Surg; 2016 Mar; 86(3):148-51. PubMed ID: 26861622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab for Crohn's Disease Patients with Perianal Fistulas: Better Image, Better Life.
    Hong L; Zhang C; Fan R; Wang L; Wang Z; Zhang T; Zhong J
    Med Sci Monit; 2020 Aug; 26():e925018. PubMed ID: 32785211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
    Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
    Cosnes J; Sokol H; Bourrier A; Nion-Larmurier I; Wisniewski A; Landman C; Marteau P; Beaugerie L; Perez K; Seksik P
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1102-1113. PubMed ID: 27666569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice.
    Bourikas LA; Koutroubakis IE
    Curr Drug Targets; 2010 Feb; 11(2):187-97. PubMed ID: 19916954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.